Somewhat Favorable Press Coverage Somewhat Unlikely to Affect MetLife (MET) Stock Price

Headlines about MetLife (NYSE:MET) have trended somewhat positive this week, according to Accern. Accern scores the sentiment of press coverage by reviewing more than twenty million news and blog sources in real time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. MetLife earned a media sentiment score of 0.05 on Accern’s scale. Accern also assigned news headlines about the financial services provider an impact score of 43.3404145303348 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the company’s share price in the near future.

These are some of the news headlines that may have impacted Accern’s scoring:

MET traded up $0.34 during trading hours on Thursday, hitting $48.17. 4,057,372 shares of the stock were exchanged, compared to its average volume of 6,819,167. MetLife has a 12 month low of $43.38 and a 12 month high of $55.91. The stock has a market capitalization of $49,354.58, a PE ratio of 10.70, a price-to-earnings-growth ratio of 0.85 and a beta of 1.24. The company has a debt-to-equity ratio of 0.29, a current ratio of 0.15 and a quick ratio of 0.15.

MetLife (NYSE:MET) last posted its earnings results on Tuesday, February 13th. The financial services provider reported $0.64 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.05 by ($0.41). The company had revenue of $15.79 billion during the quarter, compared to the consensus estimate of $15.89 billion. MetLife had a net margin of 5.69% and a return on equity of 8.59%. During the same quarter in the previous year, the business posted $1.28 earnings per share. research analysts anticipate that MetLife will post 4.91 earnings per share for the current fiscal year.

The business also recently announced a quarterly dividend, which will be paid on Wednesday, June 13th. Shareholders of record on Monday, May 7th will be paid a $0.42 dividend. This represents a $1.68 dividend on an annualized basis and a yield of 3.49%. This is a boost from MetLife’s previous quarterly dividend of $0.40. The ex-dividend date of this dividend is Friday, May 4th. MetLife’s dividend payout ratio (DPR) is presently 35.56%.

Several research firms have recently commented on MET. Zacks Investment Research cut MetLife from a “buy” rating to a “hold” rating in a research note on Monday, January 22nd. Deutsche Bank started coverage on MetLife in a research note on Tuesday, January 2nd. They set a “hold” rating and a $55.00 price objective on the stock. Goldman Sachs restated a “buy” rating on shares of MetLife in a research note on Wednesday, January 31st. Wells Fargo reduced their price objective on MetLife from $61.00 to $60.00 and set a “buy” rating on the stock in a research note on Tuesday, January 30th. Finally, ValuEngine cut MetLife from a “strong-buy” rating to a “buy” rating in a research note on Friday, February 2nd. One analyst has rated the stock with a sell rating, ten have given a hold rating and ten have assigned a buy rating to the company’s stock. The stock has an average rating of “Hold” and an average price target of $57.63.

MetLife Company Profile

MetLife, Inc engages in the insurance, annuities, employee benefits, and asset management businesses. It operates through five segments: U.S.; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short- and long-term disability, individual disability, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and stable value products, including general and separate account guaranteed interest contracts, and private floating rate funding agreements.

Insider Buying and Selling by Quarter for MetLife (NYSE:MET)

Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.




Leave a Reply